BlueCrest Capital Management
MYOK

BlueCrest Capital Management’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

BlueCrest Capital Management’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-5,949
Closed -$388K – 1626
2018
Q3 		$388K Buy
+5,949
New +$350K 0.01% 894

Other funds holding MYOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

BlueCrest Capital Management's MYOK Position: Q4 2018 in Review

BlueCrest Capital Management sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2018, closing a stake of 5,949 shares — an estimated $388K sold.

BlueCrest Capital Management first reported a position in MYOK in Q3 2018 and held it in 1 quarter. The position peaked at $388K in Q3 2018. 145 funds tracked by Wall St. Rank hold MYOK as of Q4 2018.

  • BlueCrest Capital Management reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
  • BlueCrest Capital Management sold 5,949 MyoKardia, Inc. Common Stock shares in Q4 2018, an estimated $388K.
  • BlueCrest Capital Management first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 1 quarter.
  • BlueCrest Capital Management's MyoKardia, Inc. Common Stock position peaked at $388K in Q3 2018.
  • 145 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2018.

Based on BlueCrest Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.